Aseptisches Durchstechsystem
Anmelder: Regeneron Pharmaceuticals, Inc. 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4772214
- Anmeldetag
- 10. März 2016
- Veröffentlichung
- 8. Juli 2026
- Rechtsraum
- EP
- IPC
- A61M5/24
Abstract
The present disclosure provides aseptic vial piercing and sterilization systems, and methods of assembling, using and sterilizing same. The systems and methods utilize a pre-sterilized primary container including a first end, a first cavity, a second end with an opening in communication with the first cavity, a septum at least partially sealing the opening, and a product within the first cavity. The systems and methods include an injection assembly including a first end portion of a hollow flowpath forming member. The injection assembly and the primary container may be assembled in a non-sterile environment to form a second cavity extending about the first end portion of the flowpath forming member and to the primary container. The second cavity may then be selectively sterilized in a non-deleterious manner to the product to allow the first end portion to aseptically pierce the septum to extend into the first cavity.
Anmelder
- Firma
- Regeneron Pharmaceuticals, Inc.
- Land
- 🇺🇸 USA
US-amerikanisches Biotechnologieunternehmen mit Sitz in Tarrytown, New York. Es entwickelt biopharmazeutische Wirkstoffe, unter anderem monoklonale Antikörper zur Behandlung von Augen-, Immun- und Krebserkrankungen.
1.286 Patente in unserer Datenbank
Vertreten von
-
Eisenführ Speiser
Eisenführ Speiser · München